- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
374 CHAPTER 8 Stone disease
Intracorporeal techniques of stone fragmentation (fragmentation within the body)
Electrohydraulic lithotripsy (EHL)
EHL was the first technique developed for intracorporeal lithotripsy. A high voltage applied across a concentric electrode under water generates a spark. This vaporizes water, and the subsequent expansion and collapse of the gas bubble generates a shock wave.
EHL is an effective form of stone fragmentation. The shock wave is not focused, so the EHL probe must be applied within 1 mm of the stone to optimize stone fragmentation.
EHL has a narrower safety margin than that of pneumatic, ultrasonic, or laser lithotripsy and should be kept as far away as possible from the wall of the ureter, renal pelvis, or bladder to limit damage to these structures, and at least 2 mm away from the cystoscope, ureteroscope, or nephroscope to prevent lens fracture.
Principal uses are for bladder stones (wider safety margin than in the narrower ureter).
Pneumatic (ballistic) lithotripsy
A metal projectile contained within the handpiece is propelled backward and forward at great speed by bursts of compressed air (see Fig. 8.3). It strikes a long, thin, metal probe at one end of the handpiece at 12Hz (12 strikes/second) transmitting shock waves to the probe, which, when in contact with a rigid structure such as a stone, fragments the stone.
This technique is used for stone fragmentation in the ureter (using a thin probe to allow insertion down a ureteroscope) or kidney (a thicker probe may be used, with an inbuilt suction device—Lithovac—to remove stone fragments).
Pneumatic lithotripsy is very safe, since the excursion of the end of probe is about a millimeter, and it bounces off the pliable wall of the ureter. Ureteric perforation is therefore rare.
The device is low cost and requires low maintenance. However, its ballistic effect has a tendency to cause stone migration into the proximal ureter or renal pelvis, where the stone may be inaccessible to further treatment. The metal probe cannot bend around corners, so it cannot be used for ureteroscopic treatment of stones within the kidney or with a flexible ureteroscope.
Its principal use is for ureteric stones.
Ultrasonic lithotripsy
An electrical current applied across a piezoceramic plate located in the ultrasound transducer generates ultrasound waves of a specific frequency (23,000–25,000 Hz). The ultrasound energy is transmitted to a hollow metal probe, which in turn is applied to the stone (see Fig. 8.4).
INTRACORPOREAL TECHNIQUES OF STONE FRAGMENTATION 375
Metal projectile
Probe (1–3.5mm)
Jackhammer effect
Connection to generator
Figure 8.3 The Lithoclast: a pneumatic lithotripsy device. This figure was published in Walsh PC, et al. Campbell’s Urology, 8th edition, pp. 3395–979. Copyright Elsevier 2002.
Ultrasound generator
Piezoceramic elements
Longitudinal vibration
Ultrasound |
|
probe |
Acoustical end parts |
Suction |
Foot |
|
piece |
Figure 8.4 The Calcuson: an ultrasonic lithotripsy device. This figure was published in Walsh PC, et al. Campbell’s Urology, 8th edition, pp. 3395–979. Copyright Elsevier 2002.
The stone resonates at high frequency and this causes it to break into small fragments (the opera singer breaking a glass) that are then sucked out through the center of the hollow probe. Soft tissues do not resonate when the probe is applied to them and thus are not damaged.
This technique can only be used down straight, rigid instruments. Principal uses include fragmentation of renal calculi during PCNL.
376 CHAPTER 8 Stone disease
Laser lithotripsy
The holmium:YAG laser is principally a photothermal mechanism of action, causing stone vaporization. It has minimal shock-wave generation and therefore less risk of causing stone migration. The laser energy is delivered down fibers that vary in diameter from 200 to 360 microns. The 200-micron fiber is very flexible and can be used to gain access to stones even within the lower pole of the kidney (see Figs. 8.5 and 8.6).
The zone of thermal injury is limited to 0.5–1 mm from the laser tip. No stone can withstand the heat generated by the Ho:YAG laser. Laser lithotripsy takes time; however, since the thin laser fiber must be “painted” over the surface of the stone to vaporize it.
Principal uses are for ureteric stones and small intrarenal stones.
INTRACORPOREAL TECHNIQUES OF STONE FRAGMENTATION 377
Figure 8.5 A laser fiber.
Figure 8.6 Access to the lower pole of the kidney with a flexible ureteroscope.
378 CHAPTER 8 Stone disease
Kidney stone treatment: flexible ureteroscopy and laser treatment
The development of small-caliber ureteroscopes with active deflecting mechanisms and instrument channels, in combination with the development of laser technology, small-diameter laser fibers, and stone baskets and graspers, has opened the way for intracorporeal, endoscopic treatment of kidney stones.
Access to virtually the entire collecting system is possible with modern instruments. The holmium:YAG laser has a minimal effect on tissues at distances of 2–3 mm from the laser tip and so collateral tissue damage is minimal with this laser type.
Flexible ureteroscopy and laser fragmentation offers a more effective treatment option than ESWL, with a lower morbidity than PCNL, but usually requires a general anesthetic (some patients will tolerate it with sedation alone). It can also allow access to areas of the kidney where ESWL is less efficient or where PCNL cannot reach. It is most suited to stones <2 cm in diameter.
Indications for flexible ureteroscopic kidney stone treatment
-ESWL failure
-Lower pole stone (reduces likelihood of stone passage postESWL— fragments have to pass uphill)
-Cystine stones
-Obesity such that PCNL access is technically difficult or impossible (nephroscopes may not be long enough to reach stone)
-Obesity such that ESWL is technically difficult or impossible. BMI >28 is associated with lower ESWL success rates. Treatment distance may exceed focal length of lithotriptor.
-Musculoskeletal deformities such that stone access by PCNL or ESWL is difficult or impossible (e.g., kyphoscoliosis)
-Stone in a calyceal diverticulum (accessing stones in small diverticulae in upper and anterior calyces is difficult and carries significant risks)
-Stenosis of a calyceal infundibulum or tight angle between renal pelvis and infundibulum. The flexible ureteroscope can negotiate acute angles and the laser can be used to divide obstructions.
-Bleeding diathesis where reversal of this diathesis is potentially dangerous or difficult
-Horseshoe or pelvic kidney. ESWL fragmentation rates are only 50% in such cases1 due to difficulties of shock-wave transmission through overlying organs (bowel). PCNL for such kidneys is difficult because of bowel proximity and variable blood supply (blood supply derived from multiple sources).
-Patient preference
1 Kupeli B, Isen K, Biri H, et al. (1999). Extracorporeal shockwave lithotripsy in anomalous kidneys.
J Endourol 13:39–52.
KIDNEY STONE TREATMENT 379
Disadvantages
Efficacy diminishes as stone burden increases—it simply takes a long time to paint the surface of the stone with laser energy, causing fragmentation.
A dust cloud is produced as the stone fragments, and this temporarily obscures the view until it has been washed away by irrigation. Stone fragmentation rates for those expert in flexible ureteroscopy are ~70–80% for stones <2 cm in diameter and 50% for those >2 cm in diameter,2 and ~10% of patients will require two or more treatment sessions.
2 Dasgupta P, et al. (2004). Flexible ureterorenoscopy: prospective analysis of the Guy’s experience. Ann R Coll Surg 86:367–370.